Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP111 is classified as a pseudogene homologous to RN7SK, a functional noncoding small nuclear RNA involved in regulating transcription elongation in human cells[3]. Unlike RN7SK, RN7SKP111 does not encode a functional RNA or protein, and there is no evidence of its translation, biological activity, or clinical relevance. Pseudogenes are genomic sequences similar to known genes but typically lack the ability to produce functional molecules due to disabling mutations or truncations. As a pseudogene, RN7SKP111 has no established biological role or disease association and is not considered a therapeutic target[3].
None applicable—no drugs target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 111 (RN7SKP111).